DEAFinal Rule
Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance
HealthcareOther
Ad Space (leaderboard)
Summary
The DEA is officially listing dipentylone as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess without a license. This action is part of the government's effort to control synthetic drugs that pose health and safety risks to the public.
Key Points
- 1Dipentylone, a synthetic stimulant drug, is now formally classified as Schedule I, the most restrictive category for illegal drugs with no accepted medical use
- 2Manufacturing, selling, or possessing dipentylone becomes a federal crime with potential prison time and fines for violators
- 3Law enforcement agencies now have clear legal authority to prosecute anyone involved in dipentylone production or distribution
- 4This listing may affect legitimate chemical and pharmaceutical companies that need to ensure they are not producing or handling this substance
- 5The regulation took effect on the published date and applies nationwide
Key Dates
Published
August 8, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)